Similar to various OMGCTs, KPNA2-extensive expression immature teratomas patients have a significantly lower OS and DFS when compared to KPNA2-negative patients (P = 0.0012, P = 0.0006, respectively). This evidence concerns the gene KPNA2 and teratoma.